OGN
Organon
Stock
Stock
ISIN: US68622V1061
Ticker: OGN
US68622V1061
OGN
Price
Price
CHART BY
Historical dividends and forecast
Organon has so far distributed $0.28 in 2025. The next dividend will be paid on 13.06.2025
$1.008
CHART BY
Frequently asked questions
What is Organon's market capitalization?
The market capitalization of Organon is $2.79B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Organon's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Organon is 3.25. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Organon?
Organon's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $3.334. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Organon's stock?
Currently, 8 analysts cover Organon's stock, with a consensus target price of $20.00. Analyst ratings provide insights into the stock's expected performance.
What is Organon's revenue over the trailing twelve months?
Over the trailing twelve months, Organon reported a revenue of $6.40B.
What is the EBITDA for Organon?
Organon's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $1.77B. EBITDA measures the company's overall financial performance.
What is the free cash flow of Organon?
Organon has a free cash flow of $764.00M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Organon have, and what sector and industry does it belong to?
Organon employs approximately 10,000 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of Organon's shares?
The free float of Organon is 257.08M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $2.79B
- EPS (TTM)
- $3.334
- Free Float
- 257.08M
- P/E ratio (TTM)
- 3.25
- Revenue (TTM)
- $6.40B
- EBITDA (TTM)
- $1.77B
- Free Cashflow (TTM)
- $764.00M
Pricing
- 1D span
- $10.87$11.22
- 52W span
- $10.76$23.10
Analyst Ratings
The price target is $20.00 and the stock is covered by 8 analysts.
Buy
3
Hold
2
Sell
3
Information
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
- Employees
- 10,000
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- US68622V1061
- Primary Ticker
- OGN
Knockouts
LSX Data · Fundamentals & EOD data from FactSet